Nobivac Intra-Trac 3 ADT
Canine Adenovirus 2, Canine Parainfluenza Virus (modified live viruses), Bordetella Bronchiseptica (avirulent live culture); intranasal administration with unique Advanced Delivery Technology (ADT). An aid in the prevention of disease associated with canine adenovirus type 2, canine parainfluenza virus, and Bordetella bronchiseptica infection. This vaccine is licensed to be administered in a small dose of 0.5 ml to one nostril from 3 weeks of age. ADT Technology allows needleless preparation and administration of the vaccine, therefore helps in avoiding accidental injection of this intranasal vaccine.